↓ Skip to main content

Is kallikrein-8 a blood biomarker for detecting amnestic mild cognitive impairment? Results of the population-based Heinz Nixdorf Recall study

Overview of attention for article published in Alzheimer's Research & Therapy, December 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)

Mentioned by

news
1 news outlet
twitter
1 X user

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Is kallikrein-8 a blood biomarker for detecting amnestic mild cognitive impairment? Results of the population-based Heinz Nixdorf Recall study
Published in
Alzheimer's Research & Therapy, December 2021
DOI 10.1186/s13195-021-00945-x
Pubmed ID
Authors

Sara Schramm, Martha Jokisch, Karl-Heinz Jöckel, Arne Herring, Kathy Keyvani

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Professor 2 15%
Researcher 2 15%
Lecturer > Senior Lecturer 1 8%
Student > Bachelor 1 8%
Other 1 8%
Other 2 15%
Unknown 4 31%
Readers by discipline Count As %
Neuroscience 3 23%
Medicine and Dentistry 2 15%
Agricultural and Biological Sciences 1 8%
Chemical Engineering 1 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 8%
Other 1 8%
Unknown 4 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 December 2021.
All research outputs
#3,338,746
of 23,577,654 outputs
Outputs from Alzheimer's Research & Therapy
#892
of 1,300 outputs
Outputs of similar age
#81,077
of 511,340 outputs
Outputs of similar age from Alzheimer's Research & Therapy
#27
of 39 outputs
Altmetric has tracked 23,577,654 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,300 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.8. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 511,340 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.